LeMaitre Vascular is the Market Leader in Numerous Niches for the Treatment of Peripheral Vascular Diseases - Share at all-Time High!

C. Ferrario
Lesedauer: 2 Minuten

The medical technology company LeMaitre Vascular (LMAT) supplies products for the treatment of peripheral vascular diseases. The range includes catheters, stents, biological implants and other medical instruments to improve blood flow. End-stage renal disease and, to a lesser extent, cardiovascular disease are also addressed. Peripheral vascular disease affects an estimated 200 million people worldwide. The disease covers a range of conditions in which the arteries or veins that carry blood to or from the legs, arms or organs outside the heart become...

Read this article now with a free account.

Your benefits:

  • Every month, you can read 5 articles from the premium section for free.
  • Monthly 2 trial issues of the Trader newspaper for free.
  • Create a personal watchlist with an overview of news about your stock.
Trader Times
Free account
Here we go!
Image 1Image 2Image 3

Already registered? Log In

"Tesla in a Similar Position to NVIDIA Before the Hype" - Elon Musk Talks About Robotaxi and the Potential of Humanoid Robots

At an event, Tesla CEO Elon Musk explained his thoughts on the future of the electric car manufacturer and the influence of AI. Investors and Teslafans...

Adobe expands Creative Cloud with over 100 new features - Firefly created 1 billion AI images last month alone!

At Adobe MAX, the world's largest creative trade show, held from October 10 to October 12, the leading image-editing software provider unveiled new models...

array (
  'ID' => '3733',
  'post_author' => 
  array (
    'ID' => '3',
    'user_url' => '',
    'display_name' => 'Chiara Ferrario',
    'user_registered' => '2023-09-12 13:13:33',
    'nickname' => 'ChiaraFerrario',
    'first_name' => 'Chiara',
    'last_name' => 'Ferrario',
    'description' => '',
    'description_en' => '',
    'description_es' => '',
    'description_fr' => '',
    'description_it' => '',
    'freelancer' => '0',
    'passive' => '0',
    'twitter_link' => '',
    'profile_image' => '',
    'name' => 'Chiara Ferrario',
    'name_short' => 'C. Ferrario',
    'slug' => 'chiara-ferrario',
  ),
  'post_date' => '2024-05-07 14:45:12',
  'post_date_gmt' => '2024-05-07 12:45:12',
  'post_content' => '

The medical technology company LeMaitre Vascular (LMAT) supplies products for the treatment of peripheral vascular diseases. The range includes catheters, stents, biological implants and other medical instruments to improve blood flow. End-stage renal disease and, to a lesser extent, cardiovascular disease are also addressed. Peripheral vascular disease affects an estimated 200 million people worldwide. The disease covers a range of conditions in which the arteries or veins that carry blood to or from the legs, arms or organs outside the heart become narrowed or even blocked.

More than half of the approximately 23,000 vascular surgeons worldwide use LeMaitre Vascular products. The company primarily sells directly to hospitals in 29 countries, although more than 65 countries can already be reached via distribution partners. This means that there are relationships with around 4,900 hospitals, which place average orders of $38,000 per year. Thanks to the differentiated products, price increases, such as around 12% last year, can also be realized time and again. In 9 of a total of 12 niche markets, the company sees itself as the market leader or at least the second-largest supplier with sales potential totaling $850 million.

In the first quarter, business grew by just under 14% and net profit also improved by 62%. Growth rates are high in the Asia-Pacific region at 44%. In Europe, too, the fastest-growing US product, which generated $33 million last year, is likely to come to Europe in the near future. Special biological vascular grafts from bovine carotid arteries can improve blood flow here in the long term, particularly in patients with hemodialysis access (blood purification in kidney failure). The sales forecast offered for 2024 signals growth of 10-12%. The annual target for the operating margin was raised from 19% to 22%, whereupon Barrington raised the price target to $79 (Outperform) with the prospect of better earnings development. The share is now breaking out to a new all-time high.

', 'post_title' => 'LeMaitre Vascular is the Market Leader in Numerous Niches for the Treatment of Peripheral Vascular Diseases - Share at all-Time High!', 'post_excerpt' => '', 'post_status' => 'publish', 'comment_status' => 'open', 'ping_status' => 'open', 'post_password' => '', 'post_name' => 'lemaitre-vascular-is-the-market-leader-in-numerous-niches-for-the-treatment-of-peripheral-vascular-diseases-share-at-all-time-high', 'to_ping' => '', 'pinged' => '', 'post_modified' => '2024-05-07 14:45:12', 'post_modified_gmt' => '2024-05-07 12:45:12', 'post_content_filtered' => '', 'post_parent' => '0', 'guid' => 'https://tradertimes.com/wordpress/?p=3733', 'menu_order' => '0', 'post_type' => 'post', 'post_mime_type' => '', 'comment_count' => '0', '_encloseme' => '1', '_pingme' => '1', 'magazine' => array ( 'ID' => '3737', 'post_title' => 'The Trader Times #85 dated May 07, 2024', 'post_content' => '', 'post_date' => '2024-05-07 14:42:37', 'post_type' => 'tradertimes', 'post_mime_type' => '', 'post_parent' => '0', ), 'seo_description' => '', 'seo_image' => '', 'seo_title' => '', 'teaser' => '', 'category' => array ( 9 => array ( 'term_id' => '9', 'term_taxonomy_id' => '9', 'name' => 'Top Stories', 'slug' => 'top-stories', 'description' => '', 'parent' => '0', 'lang_term_taxonomy_id' => '8', 'lang_term_id' => '8', 'lang_name' => 'English', 'lang_slug' => 'en', 'translations' => array ( 'de' => 1, 'en' => 9, 'es' => 13, 'fr' => 17, 'it' => 21, ), 'seo_title' => '', 'seo_description' => '', 'seo_image' => '', 'sub_ids' => array ( 0 => 9, ), 'link' => '/top-stories/', ), ), 'link' => '/top-stories/lemaitre-vascular-is-the-market-leader-in-numerous-niches-for-the-treatment-of-peripheral-vascular-diseases-share-at-all-time-high-3733.html', 'image' => array ( 'ID' => '3732', 'post_title' => 'Treatment varicose veins team vascular surgeons Radiofrequency ablation', 'post_content' => '', 'post_date' => '2024-05-07 11:55:07', 'post_type' => 'attachment', 'post_mime_type' => 'image/jpeg', 'post_parent' => '3731', 'src' => 'https://tradertimes.com/files/2024/05/AdobeStock_629272693-scaled.jpeg', 'width' => 2560, 'height' => 1707, 'sizes' => array ( 'thumbnail' => array ( 'file' => 'https://tradertimes.com/files/2024/05/AdobeStock_629272693-150x150.jpeg', 'width' => 150, 'height' => 150, 'mime-type' => 'image/jpeg', 'filesize' => 23414, ), '1536x1536' => array ( 'file' => 'https://tradertimes.com/files/2024/05/AdobeStock_629272693-1536x1024.jpeg', 'width' => 1536, 'height' => 1024, 'mime-type' => 'image/jpeg', 'filesize' => 164868, ), '2048x2048' => array ( 'file' => 'https://tradertimes.com/files/2024/05/AdobeStock_629272693-2048x1365.jpeg', 'width' => 2048, 'height' => 1365, 'mime-type' => 'image/jpeg', 'filesize' => 245074, ), 'teaser' => array ( 'file' => 'https://tradertimes.com/files/2024/05/AdobeStock_629272693-632x280.jpeg', 'width' => 632, 'height' => 280, 'mime-type' => 'image/jpeg', 'filesize' => 47413, ), 'content' => array ( 'file' => 'https://tradertimes.com/files/2024/05/AdobeStock_629272693-1296x3545.jpeg', 'width' => 1296, 'height' => 3545, 'mime-type' => 'image/jpeg', 'filesize' => 341090, ), 'fb' => array ( 'file' => 'https://tradertimes.com/files/2024/05/AdobeStock_629272693-1200x628.jpeg', 'width' => 1200, 'height' => 628, 'mime-type' => 'image/jpeg', 'filesize' => 104648, ), ), ), 'translations' => array ( 'de' => array ( 'post_title' => 'LeMaitre Vascular ist Marktführer in zahlreichen Nischen zur Behandlung peripherer Gefäßerkrankungen – Aktie am Allzeithoch!', 'post_name' => '', 'ID' => '3731', 'post_type' => 'post', 'link' => '/de/top-storys/-3731.html', ), 'en' => array ( 'post_title' => 'LeMaitre Vascular is the Market Leader in Numerous Niches for the Treatment of Peripheral Vascular Diseases - Share at all-Time High!', 'post_name' => 'lemaitre-vascular-is-the-market-leader-in-numerous-niches-for-the-treatment-of-peripheral-vascular-diseases-share-at-all-time-high', 'ID' => '3733', 'post_type' => 'post', 'link' => '/top-stories/lemaitre-vascular-is-the-market-leader-in-numerous-niches-for-the-treatment-of-peripheral-vascular-diseases-share-at-all-time-high-3733.html', ), 'es' => array ( 'post_title' => 'LeMaitre Vascular es líder de mercado en numerosos nichos para el tratamiento de enfermedades vasculares periféricas: ¡su acción alcanza máximos históricos!', 'post_name' => 'lemaitre-vascular-es-lder-de-mercado-en-numerosos-nichos-para-el-tratamiento-de-enfermedades-vasculares-perifricas-su-accin-alcanza-mximos-histricos', 'ID' => '3734', 'post_type' => 'post', 'link' => '/es/noticias-principales/lemaitre-vascular-es-lder-de-mercado-en-numerosos-nichos-para-el-tratamiento-de-enfermedades-vasculares-perifricas-su-accin-alcanza-mximos-histricos-3734.html', ), ), )